Metabolic Health, Diabetes & Obesity
Vaccines
Biotech- and Nanotechnology
Ph.D
Canada
Re-establishing self-tolerance by targeting MHC class II-restricted autoimmunity
A nanovaccine for juvenile diabetes
To add or modify information on this page, please contact us at the following address: community.research@axa.com

Javier
CLEMENTE-CASARES
Institution
University of Calgary
Country
Canada
Nationality
Spanish
Related articles
Chronic & Non-communicable Diseases
Medical Treatment & Drug Development
Chronic Pain & Musculoskeletal Disorders
Drug Delivery
Biotech- and Nanotechnology
AXA Project
France
Pain Pediatric & Elderly AXA Research Lab (PEARL)
Chronic pain is recognized as a major public health problem affecting patients in their daily activity, physical and mental health,... Read more

Celine
GRECO
Hôpital Necker-Enfants Malades
Medical Treatment & Drug Development
Drug Delivery
Biotech- and Nanotechnology
Mécénat des Mutuelle
France
Accelerating drug innovation with the Euridis school and its DDD Challenge
The project addresses a dual challenge: on one hand, the increasing complexity of drug development, which requires a thorough understanding... Read more

Laurence
SABATIER
Institut du médicament de Strasbourg
Agriculture, Crops & Soil Health
Biotech- and Nanotechnology
Insects & Microorganisms
Vaccines
Post-Doctoral Fellowship
Argentina
Harmless and Eco-Friendly Solution as an Alternative to Replace Synthetic Agrochemicals
Agrochemicals were introduced to protect crops from pests and enhance crop yields. However, they have become a long-standing concern due... Read more

Johan
RODRIGUEZ MELO